Article

Revised FDA Bill Would Cut Deficit by $370 Million

House Republicans have changed their Food and Drug Administration bill enough to get a positive score from the Congressional Budget Office.

The FDA bill is set for a floor vote this week. A new CBO analysis says the amended bill would reduce the deficit by $370 million over the next decade. The version that passed the Energy and Commerce Committee earlier this month would have added nearly $250 million to the deficit, according to CBO.

Read the full story: http://hcp.lv/KU9QMG

Source: The Hill

Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Leigh Maria Ramos-Platt, MD
Molly Dean, MSW, Siftwell
Molly Dean, MSW, Siftwell
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo